DT
RIGL icon

Diversified Trust’s Rigel Pharmaceuticals RIGL Stock Holding History

Diversified Trust’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,154
Closed -$47K – 911
2022
Q4 		$47K Buy
3,154
+1,646
+109% +$15.1K ﹤0.01% 783
2022
Q3 		$18K Buy
+1,508
New +$20.4K ﹤0.01% 758
2021
Q3 		– Sell
-3,371
Closed -$146K – 852
2021
Q2 		$146K Hold
3,371
– – 0.01% 737
2021
Q1 		$115K Sell
3,371
-347
-9% -$13.7K ﹤0.01% 724
2020
Q4 		$130K Sell
3,718
-1,530
-29% -$44.3K 0.01% 702
2020
Q3 		$126K Hold
5,248
– – 0.01% 602
2020
Q2 		$96K Buy
5,248
+4,106
+360% +$73.9K ﹤0.01% 526
2020
Q1 		$18K Hold
1,142
– – ﹤0.01% 420
2019
Q4 		$24K Buy
+1,142
New +$23.5K ﹤0.01% 449

Other funds holding RIGL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Diversified Trust's RIGL Position: Q1 2023 in Review

Diversified Trust sold out of Rigel Pharmaceuticals (RIGL) in Q1 2023, closing a stake of 3,154 shares — an estimated $47K sold.

Diversified Trust first reported a position in RIGL in Q4 2019 and held it in 9 quarters. The position peaked at $146K in Q2 2021. 124 funds tracked by Wall St. Rank hold RIGL as of Q1 2023.

  • Diversified Trust reported no remaining Rigel Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Diversified Trust sold 3,154 Rigel Pharmaceuticals shares in Q1 2023, an estimated $47K.
  • Diversified Trust first reported a position in Rigel Pharmaceuticals in Q4 2019 and held it in 9 quarters.
  • Diversified Trust's Rigel Pharmaceuticals position peaked at $146K in Q2 2021.
  • 124 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2023.

Based on Diversified Trust's 13F filing for Q1 2023, filed 7 Apr 2023.